Abstract
Key Words: Model Curricula Psychopharmacology TO THE EDITOR: We very much appreciate the efforts of the editors in preparing the special issue on "Development of Model Curricula" (1). They have done an extraordinary job of not only presenting the genetic issue of model curricula, but also outlining problems and solutions specific to psychiatry. Further, we are grateful that they featured our American Society of Clinical Psychopharmacology (ASCP) model psychopharmacology curriculum as a centerpiece of that issue, noting that of the many model curricula developed to date, ours was one of a very few that have been actually used (2). We wish to comment on some of the remarks made by the various authors who critiqued our 1998 edition of the curriculum. First, it is important to discuss some of the criticisms made by a residency training director and teacher in a "small program." Fitz-Gerald and Kablinger (3) noted that the topic of anxiety disorders should have been included in the first year and that more detailed lectures and/or outlines should be made available. This criticism brings up a more fundamental point concerning the use of the curriculum. Our objective in developing the model curriculum was to provideIf you're having problem loading pages
Try our single-page mode to load one page at a time


Preview Only. This article cannot be rented because we do not currently have permission from the publisher.
Preview Only
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy